Imagine a world where life-saving treatments are out of reach for those who need them most. This was the stark reality for many living with HIV/AIDS in the 80s and 90s, until trailblazers like Richard Jefferys stepped in to fight for change. Now, his groundbreaking work is being celebrated at the 29th Annual Jonathan Lax Memorial Lecture, hosted by The Wistar Institute on November 17th, 2025, at 6:30 pm EST. But here's where it gets even more inspiring: Jefferys, the Basic Science, Vaccines and Cure Project director at the Treatment Action Group (TAG), will deliver a public lecture titled Community Advocacy and HIV Cure-Directed Research, streaming live online for a global audience.
This event isn’t just about Jefferys, though. It’s also a night to honor Philadelphians Jay Kostman, M.D., and Robb Reichard with the Wistar Legacy Awards. Dr. Kostman, chief medical officer at Philadelphia FIGHT, is being recognized for his 25+ years of dedication to Wistar’s HIV research program. Reichard, meanwhile, is celebrated for his unwavering leadership of the AIDS Fund, a nonprofit that provides grants, financial aid, and educational initiatives to support Philadelphia’s most vulnerable individuals living with AIDS.
Jefferys’ journey as a health justice advocate began in 1994 at the AIDS Treatment Data Network in New York City, where he worked to simplify complex medical information and improve access to HIV care. By 1999, he was instrumental in the formation of the Health GAP Coalition, a global movement to ensure access to life-saving medications, particularly in the Global South. His lecture will reflect on over three decades of relentless advocacy, focusing on expanding HIV/AIDS research funding, raising awareness about clinical trials, and developing safer, more affordable treatments—all with the ultimate goal of finding a cure.
“Jonathan Lax was a beacon of hope during a time of fear and isolation for those with HIV/AIDS,” Jefferys reflects. “The grassroots movements he inspired—from ACT-UP Philadelphia’s rallies to community-led demonstrations—showed me the power of collective action. But the fight isn’t over. We still need more innovative research, better health services, and equitable access to treatments, both in the U.S. and globally.”
And this is the part most people miss: Jefferys’ work isn’t just about advocacy; it’s about making science accessible to everyone. As Luis J. Montaner, D.V.M., D.Phil., Wistar’s EVP and director of the HIV Cure and Viral Diseases Center, puts it, “Richard has rewritten the narrative on HIV, shifting the focus to cure-directed research and therapies. He bridges the gap between complex science and the community, ensuring everyone has a seat at the table.”
The Jonathan Lax Memorial Lecture, established after Lax’s passing, has become a platform for distinguished voices in HIV/AIDS research. Past speakers include Nobel Laureates Drew Weissman and Françoise Barré-Sinoussi, as well as Anthony S. Fauci, former director of the National Institute of Allergy and Infectious Diseases. This year’s event continues that legacy, offering a free, global platform for Jefferys’ insights.
But here’s the controversial question: With advancements in HIV research, why do disparities in access to treatment persist, especially in underserved communities? Jefferys’ lecture promises to tackle this head-on, inviting attendees to think critically about the future of HIV advocacy.
Don’t miss this opportunity to be part of the conversation. Register now at https://cvent.me/eAVqGP and join a global audience in honoring a true changemaker. What’s your take on the progress—and challenges—in HIV research and access? Share your thoughts in the comments below!
